RegenHU

RegenHU is a Swiss MedTech company that specializes in creating bioprinting instruments. Their mission is to enable researchers and scientists to reach new levels in their work by providing advanced bioprinting solutions. RegenHU offers a range of 3D bioprinters, including the R-GEN 100 and R-GEN 200, which utilize extrusion bioprinting technology to produce bio/organic parts using liquid feedstock.

The company's flagship product, the 3DDiscovery Evolution, was launched in 2009 and offered convergence of various printing technologies, delivering unrivalled precision and printing reproducibility. This bioprinter provided researchers with the flexibility to configure instruments according to their specific research needs. As of September 2020, the 3DDiscovery Evolution was operational in academic labs, research institutes, biotech, and pharma companies across 38 countries.

In November 2020, RegenHU introduced the R-GEN 100, a professional bioprinting 3D printer for research applications. The R-GEN 200, an industrial bioprinting 3D printer, was also launched in the same year, priced at USD 150,000 (EUR 137,971 as of November 2020). RegenHU's instruments are designed to assist the scientific community in challenging boundaries and contributing to the advancement of medicine.